Trial Profile
Phase II randomized study of nemorubicin hydrochloride (PNU-152243A) or doxorubicin administered in adult patients with unresectable hepatocellular carcinoma.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2011
Price :
$35
*
At a glance
- Drugs Nemorubicin (Primary) ; Doxorubicin
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Jun 2011 New trial record